Recall of Losartan

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

On early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to cause cancer.

The seven types of medications recalled were Losagen 50, Losagen 100, Losartas 50mg Tablets, Losartas 100mg Tablets, Tozaar Plus LS 50/12.5mg Tablet, Tozaar 50mg Tablet and Tozaar Tablet 100mg.

Deputy Minister Dr Lee Boon Chye urged those who are in possession of the aforementioned medication to return it to the supplier in exchange for other approved medication. Stern actions will also be taken on suppliers who continue to sell these medications.

However, there is no need to panic, says Dr Lee. “Do not panic if you have consumed the medications, as there are no short-term effects.”

This is not the first time losartan has been recalled from the market. Last year, a similar incident occured where the company which supplied Lostad HCT 50/12.5 mg was asked to cease its operation.

Be sure to visit your local pharmacy or clinic for any enquiries. Do not stop taking any medications on your own accord.

 

Related

With so much time now spent at home due to the COVID-19 pandemic, what shall we do besides binging on Netflix and perfecting the art of making Dalgona coffee? Yeap, tis’ the season for growth! 📈 MPS YPC Professional Development team had taken this opportunity to organize the very first YPC Live Podcast. What better...
At the Malaysian Society of Hypertension’s (MSH) 15th Annual Scientific Meeting, Professor Abdul Rashid Abdul Rahman, the Chairman Working Group on 5th Malaysian Hypertension Clinical Practice Guidelines (CPG) 2018 said that many updates can be expected from the new CPG. One of these new recommendations is the preference for validated electronic blood pressure (BP) sets over mercury sphygmomanometers....

Since our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…

Community Pharmacy Logo

Last updated on

This logo was decided recently from a logo competition carried out by the Pharmaceutical Services Division of the Ministry of Health, in collaboration with MPS.  Through a circular from the Pharmacy Enforcement Division of the Ministry of Health dated 30th January it is compulsory to display this logo at all community pharmacy premise. For existing…

This is a third update on the ongoing case regarding the abolishment of BIPK. To understand the background of the story, be sure to have a read at it here. Second update can be found here.    All eyes were on the Cabinet since its announcement of the abolishment of the Critical Allowance (BIPK). Different…

In light of COVID-19 and the resultant rapid expansion of pharmacists’ roles, Malaysian Pharmaceutical Society has released a guideline for Malaysian pharmacists. COVID-19 Pandemic Guidance Document for Malaysian Pharmacists Version 1 (March 2020) outlines 3 main points that pharmacists can take to ensure optimum participation in the crisis together with other healthcare professionals. The main…

Others

We are very honor to be mentioned byInternational Pharmaceutical Federation (FIP)Education report as one of the bodies along with#MPS and Malaysian Pharmacy Students’ Association (MyPSA) in training leadership for pharmacists. We are grateful to all authors for this comprehensive report! We will do our level best in nurturing the next generation of pharmacy leaders. The full report can…

Image by cromaconceptovisual from Pixabay
In the last quarter of 2020, you have probably heard of the mutated UK variant of SARS-CoV2, B-117 that is much more infectious and responsible for two-thirds of the COVID-19 cases in the UK. It is reported that the new variant is about 30-50% more contagious than the original strain. One has to wonder, is...

You’ve Got a Friend in Me

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   1. People who talk about it are just trying to get attention. 2. It always occurs without any warning signs 3. Once people decide to do it, there is nothing you can do…

Coronavirus Declared as Global Emergency by WHO

Last updated on

The recent coronavirus outbreak took us by surprise. This storm came as sudden as a midnight deluge, and it seems like it is here to stay. Admittedly, even I myself am wearing a mask as I type this. What seem to otherwise be commonplace items such as face masks and hand sanitizers are now scarce…

MPS-YPC 2020/2021 Chairperson Remarks

Last updated on
Another term has ended for the MPS-YPC Committees of 2020/2021. As the curtain falls, here are some words from the outgoing Chairperson, Cedric Chua summarizing the achievements and challenges that his team faced throughout their term.  Dear Fellow Young Pharmacists, The challenges posed by the pandemic in the past two years have spared no one....

MOH Statement on Influenza A

Last updated on

On 4 January, the Ministry of Health has released a document pertaining the influenza situation in Malaysia. There was an increase in Influenza-like illnesses (ILI) and admission of patients due to severe acute respiratory infection (SARI) since December 2019 in several parts of the nation. This might have caused panic and unrest amongst the Rakyat…